Furthermore, PTX-3 may improve the prognostic value of recognized scales, and the modified SHFM-PTX-3, HFSS-PTX-3, and MAGGIC-PTX-3 scores provide effective methods of assessing the outcomes in patients with advanced HF awaiting HT. The gene discussed is PTX3; the disease is hydrops fetalis.